China Medical Publishes 2025 ESG Report Highlighting Low-Carbon Push, Social Outreach and Strengthened Governance

Bulletin Express
04/29

China Medical (08225) has released its 2025 Environmental, Social and Governance (ESG) Report, detailing the group’s efforts to embed sustainable practices across its real-world evidence and digital healthcare businesses.

Environmental Performance • Greenhouse-gas emissions in 2025 totalled 5.17 tonnes of CO₂e, broken down into Scope 1 at 2.79 t, Scope 2 at 1.88 t and Scope 3 at 0.50 t. • The group set a target to cut absolute GHG emissions by 10% versus 2024 and to lift the share of renewables to 20% of its energy mix by 2025. • Measures already in place include ISO 14001-aligned waste-management systems, installation of energy-saving lighting and HVAC equipment, promotion of paper-less operations and employee incentives for public-transport use.

Social Contributions and Workforce Management • During the year the company staged awareness campaigns on World No-Tobacco, Allergy, Suicide-Prevention, Alzheimer’s and ALS Days, alongside fundraising initiatives such as the “Wanquan ALS Ice Bucket Challenge”. • Employment practices emphasise equality and diversity: of seven board directors, 28.57% are women, and independent non-executive directors account for more than one-third of the board. • A multi-tier training platform (“Wanquan University”) delivered orientation, technical upskilling and compliance courses; each director received at least 15 hours of ESG-focused training. • Benefits include social insurance, housing and meal subsidies; no breaches of labour laws, child or forced labour were reported.

Governance Enhancements • The board comprises two executive, one non-executive and four independent non-executive directors, supported by audit, remuneration and nomination committees. • An enterprise-wide risk-management framework—aligned with the COSO model—integrates ESG factors; a three-line-of-defence structure and a digital monitoring platform provide real-time alerts on energy usage, data-security training completion and supplier ESG scores. • The board confirms that no significant ESG non-compliance incidents occurred in the past two years.

Outlook and Targets China Medical will continue to align its clinical research, digital-health services and supply-chain practices with its stated 10% emissions-reduction goal and 20% renewable-energy target for 2025, while sustaining community-health programmes and robust governance standards.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10